Ennature Bio Pharma Limited discloses a credit rating action
In short
Ennature Bio Pharma Limited informed the Exchange about a new credit rating on August 22, 2026. No figure, breakdown, scheme name, or validity period is stated in the text. No closing date or validity period is provided.
Why it matters
A rating agency has acted on this company's debt — check whether it's an upgrade, downgrade, or just a reaffirmation, and the stated reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.